Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia

References

• Sibai B M, Dekker G, Kupferminic M. Pre-eclampsia. Lancet 2005; 365: 785–799
   PubMed Web of Science ®Google Scholar
• Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 1992; 99: 547–553
   PubMedGoogle Scholar
• Khan K S, Wojdyla D, Say L, Gulmezoglu A M, Van Look P F. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066–1074
   PubMed Web of Science ®Google Scholar
• Lee W, O'Connell C M, Baskett T F. Maternal and perinatal outcomes of eclampsia: Nova Scotia, 1981–2000. J Obstet Gynaecol Can 2004; 26: 119–123
   PubMedGoogle Scholar
• Yucesoy G, Ozkan S, Bodur H, Tan T, Caliskan E, Vural B, Corakci A. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol Obstet 2005; 273: 43–49
   PubMedGoogle Scholar
• Pijnenborg R, Bland J M, Robertson W B, Brosens I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983; 4: 397–413
   PubMed Web of Science ®Google Scholar
• Zhou Y, Damsky C H, Fisher S J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?. J Clin Invest 1997; 99: 2152–2164
   PubMed Web of Science ®Google Scholar
• Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006; 27: 939–958
   PubMed Web of Science ®Google Scholar
• Lyall F. Mechanisms regulating cytotrophoblast invasion in normal pregnancy and pre-eclampsia. Aust N Z J Obstet Gynaecol 2006; 46: 266–273
   PubMed Web of Science ®Google Scholar
• Taylor R N, Grimwood J, Taylor R S, McMaster M T, Fisher S J, North R A. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003; 188: 177–182
   PubMed Web of Science ®Google Scholar
• Nadar S K, Karalis I, Al Yemeni E, Blann A D, Lip G Y. Plasma markers of angiogenesis in pregnancy induced hypertension. Thromb Haemost 2005; 94: 1071–1076
   PubMed Web of Science ®Google Scholar
• Teran E, Chedraui P, Racines-Orbea M, Vivero S, Villena F, Duchicela F, Nacevilla L, Schwager G, Calle A. Coenzyme Q10 levels in women with preeclampsia living at different altitudes. Biofactors 2008; 32: 185–190
   PubMed Web of Science ®Google Scholar
• Teran E, Chedraui P, Vivero S, Villena F, Duchicela F, Nacevilla L. Plasma and placental nitric oxide levels during normal pregnancy and preeclampsia in women living at different altitude. Int J Gynaecol Obstet 2004; 104: 140–142
   Google Scholar
• Sargent I L, Germain S J, Sacks G P, Kumar S, Redman C W. Trophoblast deportation and the maternal inflammatory response in preeclampsia. J Reprod Immunol 2003; 59: 153–160
   PubMed Web of Science ®Google Scholar
• Levine R J, Qian C, Leshane E S, Yu K F, England L J, Schisterman E F, Wataganara T, Romero R, Bianchi D W. Two-stage elevation of cellfree fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004; 190: 707–713
   PubMed Web of Science ®Google Scholar
• Barden A, Ritchie J, Walters B, Michael C, Rivera J, Mori T, Croft K, Beilin L. Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia. Hypertension 2001; 38: 803–808
   PubMed Web of Science ®Google Scholar
• Hubel C A, McLaughlin M K, Evans R W, Hauth B A, Sims C J, Roberts J M. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 1996; 174: 975–982
   PubMed Web of Science ®Google Scholar
• Vince G S, Starkey P M, Austgulen R, Kwiatkowski D, Redman C W. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102: 20–25
   PubMedGoogle Scholar
• Madazli R, Aydin S, Uludag S, Vildan O, Tolun N. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 2003; 82: 797–802
   PubMed Web of Science ®Google Scholar
• Benyo D F, Smarason A, Redman C W, Sims C, Conrad K P. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86: 2505–2512
   PubMed Web of Science ®Google Scholar
• Jonsson Y, Rubèr M, Matthiesen L, Berg G, Nieminen K, Sharma S, Ernerudh J, Ekerfelt C. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006; 70: 83–91
   PubMed Web of Science ®Google Scholar
• Thadhani R, Mutter W P, Wolf M, Levine R J, Taylor R N, Sukhatme V P, Ecker J, Karumanchi S A. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89: 770–775
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Kim Y M, Kim G J, Kim M R, Espinoza J, Bujold E, Goncalves L, Gomez R, Edwin S, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005; 17: 3–18
   PubMed Web of Science ®Google Scholar
• Levine R J, Lam C, Qian C, Yu K F, Maynard S E, Sachs B P, Sibal B M, Epstein F H, Romero R, Thadhani R, et al. CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992–1005
   PubMed Web of Science ®Google Scholar
• Park C W, Park J S, Shim S S, Jun J K, Yoon B H, Romero R. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia. Am J Obstet Gynecol 2005; 193: 984–989
   PubMed Web of Science ®Google Scholar
• Woolcock J, Hennessy A, Xu B, Thornton C, Tooher J, Makris A, Ogle R. Soluble Flt-1 as a diagnostic marker of pre-eclampsia. Aust N Z J Obstet Gynaecol 2008; 48: 64–70
   Google Scholar
• Shibata E, Rajakumar A, Powers R W, Larkin R W, Gilmour C, Bodnar L M, Crombleholme W R, Ness R B, Roberts J M, Hubel C A. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 2005; 90: 4895–4903
   PubMed Web of Science ®Google Scholar
• Hidalgo L A, Chedraui P A, Chavez M J. Obstetrical and neonatal outcome in young adolescents of low socio-economic status: a case control study. Arch Gynecol Obstet 2005; 271: 207–211
   PubMedGoogle Scholar
• Paredes I, Hidalgo L, Chedraui P, Palma J, Eugenio J. Factors associated with inadequate prenatal care in Ecuadorian women. Int J Gynaecol Obstet 2005; 88: 168–172
   PubMed Web of Science ®Google Scholar
• Chedraui P A, Hidalgo L A, Chavez M J, San Miguel G. Determinant factors in Ecuador related to pregnancy among adolescents aged 15 or less. J Perinat Med 2004; 32: 337–341
   PubMed Web of Science ®Google Scholar
• Schroeder B M. ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Am Fam Physician 2002; 66: 330–331
   PubMed Web of Science ®Google Scholar
• Buhimschi I A, Zhao G, Funai E F, Harris N, Sasson I E, Bernstein I M, Saade G R, Buhimschi C S. Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol 2008; 199: 551.e1–551.e16
   PubMed Web of Science ®Google Scholar
• Redman C W, Sargent I L. Pre-eclampsia, the placenta and the maternal systemic inflammatory response – a review. Placenta 2003; 24: S21–S27
   PubMed Web of Science ®Google Scholar
• Gu Y, Lewis D F, Wang Y. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. J Clin Endocrinol Metab 2008; 93: 260–266
   PubMed Web of Science ®Google Scholar
• Mitchell G B, Albright B N, Caswell J L. Effect of interleukin-8 and granulocyte colony-stimulating factor on priming and activation of bovine neutrophils. Infect Immun 2003; 71: 1643–1649
   PubMed Web of Science ®Google Scholar
• Jones S A. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 2005; 175: 3463–3468
   PubMed Web of Science ®Google Scholar